01.12.2015 | Research article | Ausgabe 1/2015 Open Access

A cohort study of 4,190 patients treated with low-intensity pulsed ultrasound (LIPUS): findings in the elderly versus all patients
- Zeitschrift:
- BMC Musculoskeletal Disorders > Ausgabe 1/2015
Competing interests
Authors’ contributions
Background
Methods
-
Date of fracture: Calendar date when the fracture occurred.
-
Date of LIPUS treatment: Calendar date when LIPUS treatment began.
-
Date that LIPUS treatment ended: Calendar date when LIPUS treatment ended.
-
Outcome: A dichotomous variable of healed or not healed at treatment end. For a fracture to be considered healed, the registry protocol specified that a fracture had to meet both clinical and radiological criteria:
-
○ No motion or crepitus at the fracture site and free of pain on manual stress.
-
○ At least three of four cortices bridged on X-ray views.
-
-
Days-to-treatment (DTT): Time from fracture to beginning of LIPUS treatment. DTT defined the cohort of patients described here (DTT ≤ 90 days).
-
Days-on-treatment (DOT): Time the patient used LIPUS before attaining an outcome.
-
Patient demographics ( e.g., age, sex, weight, height, body-mass index (BMI), etc.);
-
Bone fractured ( e.g., clavicle, femur, humerus, radius, scaphoid, tibia, ulna, etc.);
-
Type of fracture ( e.g., simple, closed, comminuted, stress, displaced, open, etc.);
-
Type of treatment ( e.g., cast, screws, nails, plates, external fixation, etc.).
-
Medical comorbidities ( e.g., smoking history, physician diagnosis of diabetes, cancer, hypertension, cardiovascular disease, osteoporosis, renal failure, etc.);
-
Use of medications ( e.g., analgesics, anticoagulants, antidiabetics, bisphosphonates, calcium channel blockers, diuretics, other cardiac medications, NSAIDs, steroids, etc.).
Results
All fractures
|
0-90 days
|
91-365 days
|
>365 days
|
|
---|---|---|---|---|
Any record in the Registry
|
11,433
|
5,765
|
4,382
|
1,286
|
Deceased
|
42
|
25
|
14
|
3
|
Lost to follow-up
|
1,556
|
740
|
609
|
207
|
Non-compliant
|
776
|
333
|
330
|
113
|
Withdrew
|
691
|
304
|
286
|
101
|
Other
|
37
|
14
|
13
|
10
|
Missing treatment outcome
|
447
|
159
|
203
|
85
|
Analyzed records in the Registry
|
7,884
|
4,190
|
2,927
|
767
|
Healed
|
7,402 (93.9%)
|
4,032 (96.2%)
|
2,709 (92.6%)
|
661 (86.2%)
|
Failed
|
482 (6.1%)
|
158 (3.8%)
|
218 (7.4%)
|
106 (13.8%)
|
Variable
|
Mean
|
SD
|
N
|
Median
|
---|---|---|---|---|
Age (years)
|
43.3
|
18.2
|
3,906
|
42.0
|
Weight (pounds)
|
171.0
|
43.3
|
3,108
|
170.0
|
Height (inches)
|
67.9
|
4.7
|
3,120
|
68.0
|
Body-Mass Index
|
25.9
|
5.5
|
3,092
|
25.1
|
Outcome (± SD)
|
N or %
|
No outcome (± SD)
|
N or %
|
Significance
|
|
---|---|---|---|---|---|
Patient age (years)
|
43.3 (±18.1)
|
4,157
|
41.4 (±17.9)
|
1,539
|
0.0004
|
Weight (lb)
|
170.5 (±43.0)
|
3,296
|
176.5 (±55.8)
|
1,030
|
0.002
|
Height (in)
|
67.9 (±4.7)
|
3,309
|
68.4 (±4.4)
|
1,031
|
0.0004
|
Body-mass index
|
25.9 (±5.5)
|
3,278
|
26.4 (±7.8)
|
1,021
|
NS
|
Days-to-treatment (mean)
|
38.6 (±24.5)
|
4,170
|
39.6 (±25.3)
|
1,567
|
NS
|
Days-on-treatment (mean)
|
118.5 (±86.0)
|
4,190
|
116.4 (±107.0)
|
1,561
|
NS
|
Female (vs. male) (%)**
|
1,745 (vs. 2,441)
|
41.7%
|
599 (vs. 957)
|
38.5%
|
NS
|
Open (vs. closed fracture) (%)**
|
710 (vs. 3,320)
|
17.6%
|
243 (vs. 1,245)
|
16.3%
|
NS
|
Number of prior procedures (mean)
|
1.5 (±0.8)
|
991
|
1.4 (±0.7)
|
368
|
NS
|
Number of comorbidities (mean)
|
1.4 (±0.7)
|
763
|
1.5 (±0.9)
|
250
|
NS
|
Number of medications (mean)
|
0.4 (±0.7)
|
2,747
|
0.4 (±0.6)
|
755
|
NS
|
Smoking years (mean)
|
5.1 (±10.6)
|
3,183
|
6.6 (±11.3)
|
1,041
|
0.0002
|
Overall
|
Heal
|
Elderly
|
Heal
|
|||||
---|---|---|---|---|---|---|---|---|
Comorbidity
|
Healed
|
Failed
|
Rate
|
Lower CI
|
Upper CI
|
Healed
|
Failed
|
Rate
|
All fractures
|
4,032
|
158
|
96.2%
|
95.7%
|
96.8%
|
780
|
38
|
95.4%
|
All closed fractures
|
3,212
|
108
|
96.7%
|
96.1%
|
97.4%
|
650
|
27
|
96.0%
|
All open fractures
|
147
|
9
|
94.2%
|
90.6%
|
97.9%
|
24
|
0
|
100.0%
|
Tibia
|
939
|
42
|
95.7%
|
94.5%
|
97.0%
|
170
|
9
|
95.0%
|
Tibia/Fibula
|
705
|
33
|
95.5%
|
94.0%
|
97.0%
|
140
|
7
|
95.2%
|
Femur
|
412
|
19
|
95.6%
|
93.7%
|
97.5%
|
136
|
4
|
97.1%
|
Metatarsal
|
423
|
7
|
98.4%
|
97.2%
|
99.6%
|
40
|
0
|
100.0%
|
Radius
|
337
|
2
|
99.4%
|
98.6%
|
100.0%
|
94
|
1
|
98.9%
|
Humerus
|
207
|
19
|
91.6%
|
88.0%
|
95.2%
|
60
|
11
|
84.5%
|
Scaphoid
|
203
|
6
|
97.1%
|
94.9%
|
99.4%
|
11
|
0
|
100.0%
|
Clavicle
|
120
|
7
|
94.5%
|
90.5%
|
98.5%
|
7
|
1
|
87.5%
|
Ankle
|
122
|
3
|
97.6%
|
94.9%
|
100.0%
|
31
|
2
|
93.9%
|
Radius/Ulna
|
144
|
7
|
95.4%
|
92.0%
|
98.7%
|
36
|
0
|
100.0%
|
Fibula
|
96
|
2
|
98.0%
|
95.2%
|
100.0%
|
7
|
0
|
100.0%
|
Ulna
|
84
|
2
|
97.7%
|
94.5%
|
100.0%
|
14
|
0
|
100.0%
|
Metacarpal
|
42
|
2
|
95.5%
|
89.3%
|
100.0%
|
4
|
0
|
100.0%
|
Healed (± SD)
|
N or %
|
Failed (± SD)
|
N or %
|
Significance
|
|
---|---|---|---|---|---|
Patient age (years)
|
43.2 (±18.1)
|
4,000
|
47.7 (±16.7)
|
157
|
0.0009
|
Weight (lb)
|
170.4 (±43.1)
|
3,166
|
173.9 (±41.9)
|
130
|
NS
|
Height (in)
|
67.9 (±4.7)
|
3,181
|
67.0 (±4.4)
|
128
|
NS
|
Body-mass index
|
25.8 (±5.5)
|
3,150
|
26.9 (±5.8)
|
128
|
NS
|
Days-to-treatment (mean)
|
38.3 (±24.3)
|
4,013
|
47.1 (±27.3)
|
157
|
0.0001
|
Days-on-treatment (mean)
|
115.6 (±83.1)
|
4,032
|
193.0 (±119.7)
|
158
|
<0.0001
|
Female (vs. male) (%)**
|
1,674 (vs. 2,356)
|
41.5%
|
71 (vs. 85)
|
45.5%
|
NS
|
Open (vs. closed fracture) (%)**
|
669 (vs. 3,212)
|
17.2%
|
41 (vs. 108)
|
27.5%
|
0.002
|
Number of prior procedures (mean)
|
1.4 (±0.8)
|
950
|
1.6 (±1.2)
|
41
|
NS
|
Number of comorbidities (mean)
|
1.4 (±0.7)
|
727
|
1.4 (±0.5)
|
36
|
NS
|
Number of medications (mean)
|
0.4 (±0.7)
|
2,639
|
0.7 (±0.9)
|
108
|
0.003
|
Smoking years (mean)
|
5.0 (±10.6)
|
3,062
|
7.2 (±11.8)
|
121
|
NS
|
Overall
|
Heal
|
Elderly
|
Heal
|
|||||
---|---|---|---|---|---|---|---|---|
Comorbidity
|
Healed
|
Failed
|
Rate
|
Lower CI
|
Upper CI
|
Healed
|
Failed
|
Rate
|
All fractures
|
4,032
|
158
|
96.2%
|
95.7%
|
96.8%
|
554
|
28
|
95.2%
|
Current smokers
|
652
|
35
|
94.9%
|
93.3%
|
96.5%
|
81
|
1
|
98.8%
|
Diabetes
|
224
|
11
|
95.3%
|
92.6%
|
98.0%
|
110
|
4
|
96.5%
|
Hypertension
|
188
|
7
|
96.3%
|
93.6%
|
99.0%
|
83
|
2
|
97.6%
|
Vascular insufficiency
|
107
|
5
|
95.5%
|
91.7%
|
99.4%
|
56
|
2
|
96.6%
|
Osteoporosis
|
80
|
5
|
94.1%
|
89.1%
|
99.1%
|
57
|
5
|
91.9%
|
Cancer
|
77
|
4
|
95.1%
|
90.3%
|
99.8%
|
50
|
2
|
96.2%
|
Cardiovascular disease
|
60
|
2
|
97.2%
|
93.3%
|
100.0%
|
54
|
2
|
96.4%
|
Alcoholism
|
68
|
3
|
95.8%
|
91.1%
|
100.0%
|
10
|
0
|
100.0%
|
Renal disease
|
44
|
1
|
97.8%
|
93.5%
|
100.0%
|
11
|
1
|
91.7%
|
Rheumatoid arthritis
|
36
|
4
|
90.0%
|
80.7%
|
99.3%
|
21
|
3
|
87.5%
|
Overall
|
Heal
|
Elderly
|
Heal
|
|||||
---|---|---|---|---|---|---|---|---|
Medication
|
Healed
|
Failed
|
Rate
|
Lower CI
|
Upper CI
|
Healed
|
Failed
|
Rate
|
No medications at all
|
1,765
|
61
|
96.7%
|
95.8%
|
97.5%
|
228
|
11
|
95.4%
|
Non-NSAID analgesic
|
301
|
19
|
94.1%
|
91.5%
|
96.7%
|
48
|
4
|
92.3%
|
Prescription NSAIDs
|
159
|
14
|
91.9%
|
87.8%
|
96.0%
|
40
|
4
|
90.9%
|
Anticoagulants
|
107
|
9
|
92.2%
|
87.4%
|
97.1%
|
54
|
2
|
96.4%
|
Non-prescription NSAIDs
|
104
|
3
|
97.2%
|
94.1%
|
100.0%
|
31
|
0
|
100.0%
|
Steroids
|
93
|
8
|
92.1%
|
86.8%
|
97.3%
|
30
|
5
|
85.7%
|
Antibiotics
|
80
|
4
|
95.2%
|
90.7%
|
99.8%
|
14
|
2
|
87.5%
|
Insulin
|
75
|
6
|
92.6%
|
86.9%
|
98.3%
|
36
|
2
|
94.7%
|
Calcium channel blockers
|
62
|
6
|
91.2%
|
84.4%
|
97.9%
|
37
|
3
|
92.5%
|